Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -31.8% | 11.6% | 10.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.8% | 72.9% | 59.4% | 53.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -181.2% | -160.6% | -255.7% | -212.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -79.8% | -71.7% | -114.3% | -94.1% |
| EPS Diluted | -2.69 | -8.47 | -14.55 | -11.85 |
| % Growth | 68.2% | 41.8% | -22.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |